Single center outcomes after temporary mechanical circulatory assist device prior to Heartmate 3 implantation – a retrospective cohort study

References

• Kurihara C, Kawabori M, Sugiura T, et al. Bridging to a long-term ventricular assist device with short-term mechanical circulatory support. Artif Organs. 2018;42(6):589–596. doi: 10.1111/aor.13112.
   PubMed Web of Science ®Google Scholar
• Urban M, Siddique A, Moulton MM, et al. Can we expect improvements in outcomes with centrifugal vs axial flow left ventricular assist devices in patients transitioned from extracorporeal life support? J Card Surg. 2019;34(11):1228–1234. doi: 10.1111/jocs.14232.
   PubMed Web of Science ®Google Scholar
• Shah P, Pagani FD, Desai SS, et al. Outcomes of patients receiving temporary circulatory support Before durable ventricular assist device. Ann Thorac Surg. 2017;103(1):106–112. doi: 10.1016/j.athoracsur.2016.06.002.
   PubMed Web of Science ®Google Scholar
• Durinka JB, Bogar LJ, Hirose H, et al. End-Organ recovery Is key to success for extracorporeal membrane oxygenation as a bridge to implantable left ventricular assist device. Asaio J. 2014;60(2):189–192. doi: 10.1097/MAT.0000000000000043.
   PubMed Web of Science ®Google Scholar
• Yoshioka D, Takayama H, Garan AR, et al. Bridge to durable left ventricular assist device for refractory cardiogenic shock. J Thorac Cardiovasc Surg. 2017;153(4):752 .e5–762.e5. doi: 10.1016/j.jtcvs.2016.10.085.
   PubMed Web of Science ®Google Scholar
• Tsyganenko D, Gromann TW, Schoenrath F, et al. Predictors of mid-term outcomes in patients undergoing implantation of a ventricular assist device directly after extracorporeal life support. Eur J Cardiothorac Surg. 2019;55(4):773–779. doi: 10.1093/ejcts/ezy351.
   PubMed Web of Science ®Google Scholar
• Saeed D, Potapov E, Loforte A, et al. Transition from temporary to durable circulatory support systems. J Am Coll Cardiol. 2020;76(25):2956–2964. doi: 10.1016/j.jacc.2020.10.036.
   PubMed Web of Science ®Google Scholar
• Imamura T, Kinugawa K, Ono M, et al. Bridge-to-bridge left ventricular assist device implantation strategy vs. primary left ventricular assist device implantation strategy. Circ J. 2020;84(12):2198–2204. doi: 10.1253/circj.CJ-20-0840.
   PubMed Web of Science ®Google Scholar
• Ton VK, Xie R, Hernandez-Montfort JA, et al. Short- and long-term adverse events in patients on temporary circulatory support before durable ventricular assist device: an IMACS registry analysis. J Heart Lung Transplant. 2020;39(4):342–352. doi: 10.1016/j.healun.2019.12.011.
   PubMed Web of Science ®Google Scholar
• Marasco SF, Lo C, Murphy D, et al. Extracorporeal life support bridge to ventricular assist device: the double bridge strategy: thoughts and progress. Artif Organs. 2016;40(1):100–106. doi: 10.1111/aor.12496.
   PubMed Web of Science ®Google Scholar
• Lebreton G, Pozzi M, Mastroianni C, et al. Extracorporeal life support as a bridge to bridge: a strategy to optimize ventricular assist device results. Eur J Cardiothorac Surg. 2015;48(5):785–791. doi: 10.1093/ejcts/ezu516.
   PubMed Web of Science ®Google Scholar
• Aubin H, Petrov G, Dalyanoglu H, et al. Four-year experience of providing mobile extracorporeal life support to out-of-center patients within a suprainstitutional network—outcome of 160 consecutively treated patients. Resuscitation. 2017;121:151–157. doi: 10.1016/j.resuscitation.2017.08.237.
   PubMed Web of Science ®Google Scholar
• Aubin H, Petrov G, Dalyanoglu H, et al. A suprainstitutional network for remote extracorporeal life support. JACC Heart Fail. 2016;4(9):698–708. doi: 10.1016/j.jchf.2016.03.018.
   PubMed Web of Science ®Google Scholar
• Kormos RL, Cowger J, Pagani FD, et al. The society of thoracic surgeons intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019;38(2):114–126. doi: 10.1016/j.healun.2018.11.013.
   PubMed Web of Science ®Google Scholar
• Kormos RL, Antonides CFJ, Goldstein DJ, et al. Updated definitions of adverse events for trials and registries of mechanical circulatory support: a consensus statement of the mechanical circulatory support academic research consortium. J Heart Lung Transplant. 2020;39(8):735–750. doi: 10.1016/j.healun.2020.03.010.
   PubMed Web of Science ®Google Scholar
• Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-year outcomes in patients With fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA. 2022;328(12):1233–1242. doi: 10.1001/jama.2022.16197.
   PubMed Web of Science ®Google Scholar
• Zimpfer D, Gustafsson F, Potapov E, et al. Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry. Eur Heart J. 2020;41(39):3801–3809. https://doi.org/10.1093/eurheartj/ehaa639.
   Google Scholar
• den Uil CA, Akin S, Jewbali LS, et al. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017;52(1):14–25. doi: 10.1093/ejcts/ezx088.
   PubMed Web of Science ®Google Scholar
• Takeda K, Naka Y, Yang JA, et al. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant. 2014;33(2):141–148. doi: 10.1016/j.healun.2013.06.025.
   PubMed Web of Science ®Google Scholar
• Schibilsky D, Haller C, Lange B, et al. Extracorporeal life support prior to left ventricular assist device implantation leads to improvement of the patients INTERMACS levels and outcome. Schäfer A, ed. PLoS One. 2017;12(3):e0174262. doi: 10.1371/journal.pone.0174262.
   PubMed Web of Science ®Google Scholar
• Mørk SR, Stengaard C, Linde L, et al. Mechanical circulatory support for refractory out-of-hospital cardiac arrest: a danish nationwide multicenter study. Crit Care. 2021;25(1):174. doi: 10.1186/s13054-021-03606-5.
   PubMed Web of Science ®Google Scholar